However, treatment with RXA restored the expression of these components in both AD mouse model and human keratinocytes, and the expression of filaggrin was significantly enhanced in the AD cocktail-induced AD-like HSE model, thus suggesting that RXA has a promising effect in enhancing the skin barrier function through the modulation of filaggrin and AhR. The gene discussed is FLG; the disease is Alzheimer disease.